Full-text resources of CEJSH and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

Results found: 2

first rewind previous Page / 1 next fast forward last

Search results

help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
EN
Introduction. The Charlson Comorbidity Index (CCI) is a comorbidity scale used widely throughout the world. Despite its widespread use, its relationship with patient readmission to the Emergency departments (ED) has not been evaluated previously. Aim. To show whether there is a correlation between the CCI score and the number of repeated admissions to ED and that the CCI score can be used as a predicted factor for the serious patients. Material and methods. This was a prospective observational cross-sectional study. Age, gender, vital signs of the patients who agreed to participate in the study was recorded. Numbers of ED readmissions of patients within six months after discharge and CCI scores have been recorded. Results. The study was completed with 1420 patients. The admission rates of patients in the ED in the six months were significantly higher in the CCI 5+ group than in other groups (p<0.05) There was a positive correlation between the number of visits and CCI scores (p<0.01; C>0). Conclusion. We believe that the CCI scoring system can be used by ED clinicians to predict the risk of readmission of patients after discharge from ED.
EN
Introduction and aim. The aim of this study is to evaluate the effects of topical lidocaine application for nasopharyngeal sampling, on pain perception, the comfort of the patients, and the application difficulty for healthcare staff. Material and methods. This study conducted with 100 healthy volunteers (50 participants in Lidocaine group and 50 participants in Placebo group). Two ml of a solution containing 10 mg/ml of lidocaine was applied to each nostril of the participants in the Lidocaine group, and the same dose of 0.9% NaCl to the Placebo group. We compared the changes in pain intensity and discomfort intensity using two numerical rating scales, the frequency of undesirable reactions, and the judgment of the practitioner staff. Results. There were statistically significant decreases in pain and discomfort scores in the Lidocaine group. Similarly, there were statistically significant decreases in the frequency of all undesirable reactions except “grimace”, in the second sampling in the Lidocaine group, however, there was a statistically significant decrease only in “holding staff’s hand” in second sampling in the Placebo group. Conclusion. Intranasal lidocaine application reduces the pain that occurs during nasopharyngeal sampling and makes the procedure easier for the patient and the healthcare worker.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.